Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	P/E Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$185.67 +0.1%	79.00	$327.94 billion	2.18 million	6.90 million	Positive News Dividend Announcement
TMO Thermo Fisher Scientific	$394.60 +0.5%	23.13	$148.88 billion	971,762	2.34 million	Positive News
DHR Danaher	$196.11 +0.9%	38.06	$140.26 billion	2.89 million	4.25 million	Positive News
VRTX Vertex Pharmaceuticals	$439.36 -2.0%	N/A	$112.86 billion	723,162	1.42 million	Positive News Analyst Forecast
GSK GSK	$38.02 -1.6%	19.59	$77.81 billion	2.58 million	5.21 million
COR Cencora	$296.02 -0.2%	34.34	$57.38 billion	618,519	1.66 million	Positive News
TAK Takeda Pharmaceutical	$14.79 -0.8%	67.21	$47.04 billion	892,935	1.99 million
VEEV Veeva Systems	$280.39 -0.4%	59.40	$45.82 billion	696,550	1.33 million	Positive News
ALNY Alnylam Pharmaceuticals	$311.36 -0.3%	N/A	$40.62 billion	195,021	929,884
CTSH Cognizant Technology Solutions	$77.15 -2.5%	16.23	$38.01 billion	2.90 million	3.78 million	Positive News
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ARGX argenex	$542.74 +0.9%	33.55	$33.21 billion	114,483	325,495	Analyst Revision
IQV IQVIA	$155.25 +0.4%	21.15	$26.86 billion	427,448	1.94 million	Positive News Short Interest ↑
BNTX BioNTech	$105.25 +0.8%	N/A	$25.31 billion	193,953	946,732	Analyst Revision
RPRX Royalty Pharma	$34.62 -0.8%	18.70	$19.45 billion	912,400	4.74 million
IFF International Flavors & Fragrances	$74.52 +0.0%	N/A	$19.06 billion	621,564	1.70 million	Positive News
ILMN Illumina	$91.00 +0.8%	N/A	$14.40 billion	457,042	2.27 million	Positive News
UTHR United Therapeutics	$290.06 -0.6%	11.57	$13.08 billion	184,735	451,730	Positive News
SUZ Suzano	$9.49 -0.9%	N/A	$12.56 billion	229,659	1.91 million	Short Interest ↑
ICLR Icon	$146.33 +1.9%	15.94	$11.82 billion	538,796	1.09 million	Positive News
RVTY Revvity	$94.90 +0.5%	40.37	$11.18 billion	191,954	1.13 million	Positive News
MRNA Moderna	$25.68 +1.1%	N/A	$9.94 billion	2.74 million	11.29 million
FN Fabrinet	$265.38 -0.1%	29.56	$9.51 billion	178,556	757,485	Positive News
MEDP Medpace	$306.70 +1.3%	23.41	$8.81 billion	83,110	364,396	Positive News
CRL Charles River Laboratories International	$147.34 +1.4%	N/A	$7.24 billion	147,504	1.39 million
BIO.B Bio-Rad Laboratories	$250.08	N/A	$6.80 billion	28	22
LITE Lumentum	$89.41 +1.1%	N/A	$6.20 billion	484,420	2.07 million
LEGN Legend Biotech	$33.10 -5.1%	N/A	$6.08 billion	492,745	1.34 million	Positive News
TGTX TG Therapeutics	$35.58 +1.2%	148.12	$5.64 billion	470,848	2.60 million
IBB iShares Biotechnology ETF	$125.53 -0.2%	N/A	$5.35 billion	519,235	1.45 million
BE Bloom Energy	$21.62 +0.6%	N/A	$5.02 billion	881,978	6.28 million	Insider Trade
PCVX Vaxcyte	$32.89 -1.5%	N/A	$4.25 billion	281,578	1.44 million	Positive News
ODD ODDITY Tech	$71.34 +2.3%	41.00	$3.98 billion	200,384	583,107	Positive News
KRYS Krystal Biotech	$131.30 -0.6%	31.56	$3.79 billion	53,061	310,127
SWTX SpringWorks Therapeutics	$46.98 +0.4%	N/A	$3.54 billion	7.13 million	2.46 million	Positive News High Trading Volume
AAPG Ascentage Pharma Group International	$37.43 +4.3%	N/A	$3.26 billion	17,706	53,684	Gap Up
HTGC Hercules Capital	$18.02 0.0%	13.55	$3.16 billion	228,296	1.26 million
IBRX ImmunityBio	$2.87 +0.9%	N/A	$2.53 billion	1.98 million	7.75 million
RDW Redwire	$16.81 +1.2%	N/A	$2.39 billion	1.52 million	2.17 million	Analyst Revision
TPC Tutor Perini	$42.39 +1.0%	N/A	$2.23 billion	158,498	652,606
TWST Twist Bioscience	$35.14 -2.1%	N/A	$2.10 billion	233,799	971,951
War Tensions Are Making Gold Rise to Record Highs (Ad) If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days. Click here to see how to secure the next payout before it's too late.
BCRX BioCryst Pharmaceuticals	$9.96 -0.1%	N/A	$2.08 billion	1.10 million	3.04 million
RXRX Recursion Pharmaceuticals	$5.10 -0.3%	N/A	$2.07 billion	12.75 million	23.96 million	Gap Up
DNLI Denali Therapeutics	$13.72 -2.7%	N/A	$1.99 billion	273,903	1.13 million	Positive News
SXI Standex International	$156.89 -0.2%	31.01	$1.89 billion	29,228	75,186
APGE Apogee Therapeutics	$41.07 -0.3%	N/A	$1.89 billion	135,604	554,004
FOLD Amicus Therapeutics	$5.69 -0.8%	N/A	$1.76 billion	1.19 million	3.02 million
BEAM Beam Therapeutics	$16.66 -1.9%	N/A	$1.68 billion	661,542	1.49 million
JTEK JPMorgan U.S. Tech Leaders ETF	$79.65 -0.4%	35.61	$1.64 billion	33,833	246,281
IMCR Immunocore	$31.94 +0.7%	N/A	$1.60 billion	181,771	347,915
ADPT Adaptive Biotechnologies	$10.47	N/A	$1.59 billion	561,957	1.57 million	Analyst Forecast
PHR Phreesia	$26.27 +2.4%	N/A	$1.56 billion	177,833	490,083
EVO Evotec	$3.82 -3.9%	N/A	$1.36 billion	24,674	134,664
AZTA Azenta	$29.46 -1.6%	N/A	$1.35 billion	69,773	699,228	Positive News
VERA Vera Therapeutics	$20.95 +0.1%	N/A	$1.34 billion	385,380	956,598	Short Interest ↑
TXG 10x Genomics	$10.71 -1.5%	N/A	$1.32 billion	591,418	3.31 million	Positive News
OCSL Oaktree Specialty Lending	$13.74 -0.4%	105.65	$1.21 billion	204,354	753,623
VRDN Viridian Therapeutics	$14.70 -2.0%	N/A	$1.20 billion	175,650	1.17 million
DYN Dyne Therapeutics	$10.23 -5.1%	N/A	$1.16 billion	817,281	2.43 million	Analyst Forecast
NVAX Novavax	$6.32 +0.2%	2.39	$1.02 billion	1.43 million	6.46 million	Analyst Forecast
WVE WAVE Life Sciences	$6.57 -4.9%	N/A	$1.01 billion	277,023	1.32 million
THR Thermon Group	$27.36 +0.3%	17.42	$905.18 million	51,916	192,237	Positive News
SYRE Spyre Therapeutics	$14.84 -1.6%	N/A	$893.35 million	183,172	604,972	Positive News
DHC Diversified Healthcare Trust	$3.71 +0.4%	N/A	$891.42 million	426,982	983,008	Positive News
ZYME Zymeworks	$12.36 -2.1%	N/A	$860.81 million	155,783	549,585	Positive News
HQH abrdn Healthcare Investors	$15.34 -0.4%	N/A	$826.21 million	83,689	212,529
COGT Cogent Biosciences	$7.02 -3.0%	N/A	$799.30 million	518,786	1.32 million	Analyst Forecast
CDMO Avid Bioservices	$12.50 +0.1%	N/A	$799.18 million	3.07 million	1.43 million	High Trading Volume
TRNS Transcat	$82.17 +1.3%	52.67	$765.78 million	30,365	87,408	Positive News
IMNM Immunome	$8.72 -1.2%	N/A	$760.47 million	190,580	1.03 million
REPL Replimune Group	$9.33 -1.7%	N/A	$719.33 million	296,069	887,490	Positive News Analyst Forecast
VIR Vir Biotechnology	$5.17 -0.9%	N/A	$714.01 million	435,655	1.71 million
URGN Urogen Pharma	$14.96 +0.6%	N/A	$690.50 million	920,870	1.61 million	Short Interest ↓ Analyst Revision
IOVA Iovance Biotherapeutics	$2.02 -1.2%	N/A	$672.87 million	2.53 million	8.92 million
UNCY Unicycive Therapeutics	$5.59 -16.3%	N/A	$670.60 million	1.10 million	208,497	High Trading Volume
ANAB AnaptysBio	$22.88 -2.2%	N/A	$667.51 million	76,572	857,057	Positive News
TCPC Blackrock Tcp Capital	$7.54 +0.3%	N/A	$639.91 million	82,662	590,085
UPB Upstream Bio	$11.34 +6.6%	N/A	$610.56 million	189,217	334,709
SANA Sana Biotechnology	$2.67 -3.4%	N/A	$600.90 million	1.11 million	5.74 million	Gap Up
DNTH Dianthus Therapeutics	$16.84 -3.5%	N/A	$541.41 million	49,290	276,719	Positive News
ARVN Arvinas	$7.40 -1.0%	N/A	$540.49 million	507,334	1.44 million	Positive News
TNGX Tango Therapeutics	$4.93 +2.7%	N/A	$535.58 million	428,208	1.48 million	Gap Up
DNA Ginkgo Bioworks	$8.57 -0.1%	N/A	$502.19 million	263,403	1.44 million
FTRE Fortrea	$5.39 -1.1%	N/A	$487.80 million	207,308	2.37 million
TYRA Tyra Biosciences	$9.19 -3.3%	N/A	$487.10 million	117,286	279,280
CAPR Capricor Therapeutics	$10.38 -13.1%	N/A	$475.80 million	3.46 million	1.85 million	Analyst Forecast
SEPN Septerna	$10.67 +1.7%	N/A	$475.23 million	349,069	815,621	Upcoming Earnings
CELC Celcuity	$11.66 -1.3%	N/A	$441.56 million	53,400	287,465	Positive News
AMLX Amylyx Pharmaceuticals	$4.95 -3.0%	N/A	$440.80 million	257,672	1.20 million	Analyst Forecast
ORKA Oruka Therapeutics	$11.76 -1.9%	N/A	$440.11 million	18,982	219,429
WNC Wabash National	$10.42 +0.3%	N/A	$436.29 million	155,885	1.05 million
War Tensions Are Making Gold Rise to Record Highs (Ad) If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days. Click here to see how to secure the next payout before it's too late.
TRML Tourmaline Bio	$16.90 +0.4%	N/A	$434.10 million	103,513	272,921	Positive News
RGNX REGENXBIO	$8.41 -1.9%	N/A	$422.35 million	240,288	925,133	Positive News
PRTC PureTech Health	$17.53 -2.1%	N/A	$420.95 million	271	4,675	Gap Down
ZYBT Zhengye Biotechnology	$8.57 +5.9%	N/A	$404.25 million	158,332	382,918
LAB Standard BioTools	$1.06 -3.2%	N/A	$400.71 million	518,972	2.07 million
RAPP Rapport Therapeutics	$10.76 -2.5%	N/A	$392.56 million	24,567	167,380
BNTC Benitec Biopharma	$14.50 -3.0%	N/A	$385.56 million	15,510	43,678	Positive News
ABVX Abivax	$6.08 +0.4%	N/A	$385.40 million	54,962	154,703	Gap Up
RWAY Runway Growth Finance	$10.31 -0.2%	6.21	$384.90 million	88,454	315,792	Positive News Analyst Revision
VIGL Vigil Neuroscience	$7.91 -0.2%	N/A	$368.94 million	285,029	737,593

Resources

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools